法国全科医生疫苗犹豫的患病率及相关因素:2014年4月至7月一项横断面电话调查
该研究旨在估计法国全科医生(GP)中疫苗犹豫(VH)的患病率,并研究其人口学、职业和个人相关因素。2014年对法国私人执业全科医生全国性小组中随机选取的1712名GP进行横断面电话调查,通过聚类分析识别出三个VH集群。结果显示86%的GP(95%CI:84-88)不犹豫或仅轻度犹豫,11%(95%CI:9-12)中度犹豫,3%(95%CI:3-4)高度犹豫或反对接种。
要点
- 86%的法国GP不犹豫或仅轻度疫苗犹豫(95%CI:84-88)。
- 11%的GP中度疫苗犹豫(95%CI:9-12),3%高度犹豫或反对接种(95%CI:3-4)。
- 中度和高度犹豫的GP疫苗接种率较低,更常报告替代医学实践,较少经历疫苗可预防疾病,更多遇到他们认为有严重不良反应的患者。
核心结论
- 本研究证实法国全科医生中存在疫苗犹豫,但其患病率中等。
- 鉴于全科医生在疫苗接种中的核心作用,这些结果呼吁利益相关方动员起来应对全科医生的疫苗犹豫。
研究设计与样本
- 横断面电话调查,2014年4月至7月在法国私人执业全科医生全国性小组中进行。
- 样本为从法国卫生专业人员详尽数据库中随机选取的1712名全科医生。
- 通过聚类分析疫苗犹豫的多个维度(自我报告的疫苗推荐、对疫苗风险和有用性的感知)识别集群。
主要发现
- 86%的全科医生不犹豫或仅轻度犹豫(95%CI:84-88)。
- 11%的全科医生中度犹豫(95%CI:9-12)。
- 3%的全科医生高度犹豫或反对接种(95%CI:3-4)。
- 中度和高度犹豫集群的全科医生疫苗接种频率较低,更常报告偶尔实践替代医学,较少经历疫苗可预防疾病,更多遇到他们认为有严重不良反应的患者。
关键数值与推荐
- 疫苗犹豫通过聚类分析分为三个集群:不犹豫或轻度犹豫(86%,95%CI:84-88)、中度犹豫(11%,95%CI:9-12)、高度犹豫或反对接种(3%,95%CI:3-4)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
This article sought to estimate the prevalence of vaccine hesitancy (VH) among French general practitioners (GPs) and to study its demographic, professional and personal correlates. We conducted a cross-sectional telephone survey about GPs' vaccination-related attitudes and practices in 2014 in a national panel of 1,712 GPs in private practice, randomly selected from an exhaustive database of health professionals in France. A cluster analysis of various dimensions of VH (self-reported vaccine recommendations, perceptions of vaccine risks and usefulness) identified three clusters: 86% of GPs (95% confidence interval (CI): 84-88) were not or only slightly vaccine-hesitant, 11% (95% CI: 9-12) moderately hesitant and 3% (95% CI: 3-4) highly hesitant or opposed to vaccination. GPs in the latter two clusters were less frequently vaccinated and reported occasional practice of alternative medicine more often than those in the first cluster; they also described less experience with vaccine-preventable diseases and more experience with patients who they considered had serious adverse effects from vaccination. This study confirms the presence of VH among French GPs but also suggests that its prevalence is moderate. Given GPs' central role in vaccination, these results nevertheless call for a mobilisation of stakeholders to address VH among GPs.
引用
- Verger P, Collange F, Fressard L, et al. Prevalence and correlates of vaccine hesitancy among general practitioners: a cross-sectional telephone survey in France, April to July 2014. Euro Surveill. 2016. PMID: 27918262. doi:10.2807/1560-7917.ES.2016.21.47.30406
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。